0001190725-16-000428.txt : 20160614
0001190725-16-000428.hdr.sgml : 20160614
20160614151615
ACCESSION NUMBER: 0001190725-16-000428
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160614
FILED AS OF DATE: 20160614
DATE AS OF CHANGE: 20160614
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Mirati Therapeutics, Inc.
CENTRAL INDEX KEY: 0001576263
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 462693615
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9393 TOWNE CENTRE DRIVE
STREET 2: SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-332-3410
MAIL ADDRESS:
STREET 1: 9393 TOWNE CENTRE DRIVE
STREET 2: SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BAUM CHARLES M
CENTRAL INDEX KEY: 0001579824
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35921
FILM NUMBER: 161712875
MAIL ADDRESS:
STREET 1: C/O MIRATI THERAPEUTICS INC.
STREET 2: 9393 TOWNE CENTRE DRIVE, STE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2016-06-14
0
0001576263
Mirati Therapeutics, Inc.
MRTX
0001579824
BAUM CHARLES M
C/O MIRATI THERAPEUTICS INC.
9393 TOWNE CENTRE DRIVE, STE 200
SAN DIEGO
CA
92121
1
1
0
0
PRESIDENT & CEO
Common Stock
2016-06-14
4
P
0
20000
7.0535
A
48556
D
The price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.96 to $7.14, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.
/s/ Jamie A. Donadio, Attorney-in-Fact
2016-06-14